These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 1833779)

  • 21. Pretreatment with serotonin 5-HT(3) receptor antagonists produces no observable blockade of long-term motor sensitization to cocaine in rats.
    Szumlinski KK; Frys KA; Kalivas PW
    Psychopharmacology (Berl); 2003 Feb; 165(4):329-36. PubMed ID: 12451437
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 5-HT3 receptor antagonists fail to block the suppressant effect of cocaine on the firing rate of A10 dopamine neurons in the rat.
    Batsche K; Granoff MI; Wang RY
    Brain Res; 1992 Oct; 592(1-2):273-7. PubMed ID: 1450916
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of the 5-HT3 antagonist GR38032F (ondansetron) on benzodiazepine withdrawal in rats.
    Goudie AJ; Leathley MJ
    Eur J Pharmacol; 1990 Aug; 185(2-3):179-86. PubMed ID: 1979273
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The interaction of cocaine with serotonin dorsal raphe neurons. Single-unit extracellular recording studies.
    Cunningham KA; Lakoski JM
    Neuropsychopharmacology; 1990 Feb; 3(1):41-50. PubMed ID: 2137698
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacological characterization of 5-hydroxytryptamine-induced excitation of afferent cervical vagus nerve in anaesthetized rats.
    Yoshioka M; Ikeda T; Abe M; Togashi H; Minami M; Saito H
    Br J Pharmacol; 1992 Jul; 106(3):544-9. PubMed ID: 1387026
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Involvement of 5-HT1, 5-HT2, and 5-HT3 receptors in the mediation of the prolactin response to serotonin and 5-hydroxytryptophan.
    Jørgensen H; Knigge U; Warberg J
    Neuroendocrinology; 1992 Mar; 55(3):336-43. PubMed ID: 1386914
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence for involvement of both D1 and D2 receptors in maintaining cocaine self-administration.
    Britton DR; Curzon P; Mackenzie RG; Kebabian JW; Williams JE; Kerkman D
    Pharmacol Biochem Behav; 1991 Aug; 39(4):911-5. PubMed ID: 1684870
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intracranial self-administration of cocaine within the posterior ventral tegmental area of Wistar rats: evidence for involvement of serotonin-3 receptors and dopamine neurons.
    Rodd ZA; Bell RL; Kuc KA; Zhang Y; Murphy JM; McBride WJ
    J Pharmacol Exp Ther; 2005 Apr; 313(1):134-45. PubMed ID: 15650115
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of 5-HT3 receptor antagonists on 5-HT and nicotinic depolarizations in guinea-pig submucosal neurones.
    Vanner S; Surprenant A
    Br J Pharmacol; 1990 Apr; 99(4):840-4. PubMed ID: 2141798
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of the serotonin 5-HT(2) antagonist, ritanserin, and the serotonin 5-HT(1A) antagonist, WAY 100635, on cocaine-seeking in rats.
    Schenk S
    Pharmacol Biochem Behav; 2000 Oct; 67(2):363-9. PubMed ID: 11124402
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The 5-HT3 antagonist Y-25130 blocks cocaine-induced lowering of ICSS reward thresholds in the rat.
    Kelley SP; Hodge CW
    Pharmacol Biochem Behav; 2003 Jan; 74(2):297-302. PubMed ID: 12479948
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The reinforcing actions of a serotonin-3 receptor agonist within the ventral tegmental area: evidence for subregional and genetic differences and involvement of dopamine neurons.
    Rodd ZA; Gryszowka VE; Toalston JE; Oster SM; Ji D; Bell RL; McBride WJ
    J Pharmacol Exp Ther; 2007 Jun; 321(3):1003-12. PubMed ID: 17325230
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detailed investigations of 5-HT3 compounds in a drug discrimination model.
    De La Garza R; Callahan PM; Cunningham KA
    Pharmacol Biochem Behav; 1996 Jul; 54(3):533-40. PubMed ID: 8743626
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of cocaine and 5-HT3 receptor antagonists on 5-HT-induced [3H]dopamine release from rat striatal synaptosomes.
    Yi SJ; Gifford AN; Johnson KM
    Eur J Pharmacol; 1991 Jun; 199(2):185-9. PubMed ID: 1835440
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Parameters of self-administration of cocaine in rats under a progressive-ratio schedule.
    Depoortere RY; Li DH; Lane JD; Emmett-Oglesby MW
    Pharmacol Biochem Behav; 1993 Jul; 45(3):539-48. PubMed ID: 8332614
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Injection of the 5-HT2C receptor agonist Ro60-0175 into the ventral tegmental area reduces cocaine-induced locomotor activity and cocaine self-administration.
    Fletcher PJ; Chintoh AF; Sinyard J; Higgins GA
    Neuropsychopharmacology; 2004 Feb; 29(2):308-18. PubMed ID: 14666118
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacological characterization of 5-hydroxytryptamine-induced apnea in the rat.
    Yoshioka M; Goda Y; Togashi H; Matsumoto M; Saito H
    J Pharmacol Exp Ther; 1992 Feb; 260(2):917-24. PubMed ID: 1531363
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Monoamine mediation of cocaine-induced hypothalamo-pituitary-adrenal activation.
    Borowsky B; Kuhn CM
    J Pharmacol Exp Ther; 1991 Jan; 256(1):204-10. PubMed ID: 1671094
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Receptor mediation of 5-HT-induced inflammation and nociception in rats.
    Sufka KJ; Schomburg FM; Giordano J
    Pharmacol Biochem Behav; 1992 Jan; 41(1):53-6. PubMed ID: 1531705
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacology and preclinical antiemetic properties of ondansetron.
    Tyers MB
    Semin Oncol; 1992 Aug; 19(4 Suppl 10):1-8. PubMed ID: 1387245
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.